#Breaking: The National Institute of #Genomics in #Bucharest will represent the first pan-European medical and research infrastructure in south-eastern Europe, in the field of genomics

Read Time3 Minute, 18 Second

The authorities will finance the establishment of the National Institute of Genomics, which will allow Romania to progress on human genetics, European Funds Minister Marcel Bolos announced, according to Agerpres. On Friday, he visited the National Institute for Mother and Child Health Alessandrescu-Rusescu, together with the institute’s manager, Nicolae Suciu, and the coordinator of the Materno-Fetal Assistance Unit of Excellence at the Institute, Dr. Dragoș Crețoiu

Cercetare de vârf în domeniul medicinei regenerative - Revista CariereAccording to a communiqué of the Ministry of European Funds, quoted by Agerpres, the meeting discussed the importance of establishing in Romania a National Institute of Genomics, whose main goal will be to promote genomic medicine, supporting the reform of medical research and health services in Romania.

In this context, Minister Marcel Bolos said that MFE will already begin the necessary steps to finance this project in the future programming period.

“The existence of such an institute in Romania will allow our country to join other states and to progress on human genetics and personalized research in the field of health. Such a project will have a particularpositive impact on oncology patients and personalised treatments, on patients with rare conditions or for detecting certain risks in pregnancy,” said the Minister of European Funds.

Genomics, the science that deals with the clinical interpretation of data obtained by sequencing the entire genome, provides an accurate diagnosis of diseases caused by genetic mutations and a personalized treatment for them, an activity that is on the frontier of personalized medicine, MFE states. Secondly, the research potential in this area, reflected in the United Nations reports and in the resolutions of the World Health Organization, will contribute significantly to scientific, economic and social development in Romania.

Nationally, the aim of the National Institute of Genomics is to reduce morbidity indicators by developing and executing genomic prevention/screening protocols and analyses, diagnosis and treatment, as well as high-performance medical services in the fields of oncology, cardiology, endocrinology, gynecology, hematology, internal medicine, gastroenterology, pediatrics, ENT, ophthalmology, maternal-fetal medicine, geriatrics and neurodegenerative diseases. Other purposes are also the sequencing of the DNA of tumor cells (from tumors or circulating in patients’ blood) for the administration of personalized treatments, the creation of a genomic and clinical database for Romania, with multiple implications in science and the exploitation of the results of research in the field by introducing them into the economic circuit in the form of new or improved products, processes and services.

At European level, participation in the Declaration of Cooperation for access to at least one million genomes sequenced in the European Union by 2022 is envisaged. “The aim is to collaborate for safe and authorised access to national and regional genetic data banks and other data relevant to health, by integrating European infrastructure and expertise into genomics, increasing the value of Member States’ investments in this field and producing clinical impact studies,” explains MFE. Also, one objective is the participation, through the Ministry of Health, in the European Partnership for Personalized Medicine, with the aim of financing, implementing and cooperation in the field of personalized medicine. This partnership will have access to specific non-refundable funds, the document said.

Internationally, it is intended to participate in the North Atlantic Treaty Organization Programme – Science for Peace and Prosperity in the field of genomics and the implementation of the World Health Organization Resolution by ensuring the necessary contribution by member governments and the scientific community to the progress of genomics. The authorities also propose the completion of clinical trials in the field of the Institute and the transition to applied medicine, with the aim of developing new therapies in tissue regeneration and autologous transplant of telocites, with the potential to revolutionize the field of regenerative medicine, putting Romania in front of competing countries.

According to the MFE, the National Institute of Genomics in Bucharest will represent the first pan-European medical and research infrastructure in south-eastern Europe, in the field of genomics.

By

Robert Williams

Editor in Chief

About Post Author

Robert Williams

Related Posts

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: